STERIS (STE) Form 144: 4,110 shares from employee option sold through Charles Schwab

Rhea-AI Filing Summary

STERIS plc (STE) filed a Form 144 reporting a proposed sale of 4,110 ordinary shares through Charles Schwab & Co., Inc., with an aggregate market value of $993,562.00 and an approximate sale date of 08/11/2025. The filing shows the securities were acquired on 08/11/2025 via an employee stock option exercise and the payment was made through a broker cashless exercise.

The table lists the issuer's shares outstanding as 98,490,606. The filing also states there were no securities sold in the past three months by the person for whose account these securities are to be sold and includes the standard attestation that the filer is not aware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Form 144 reports a small, broker-facilitated sale of employee-option shares totaling $993,562.

The filing discloses a proposed sale of 4,110 ordinary shares acquired via an employee stock option exercise and settled through a broker cashless exercise. Execution is routed through Charles Schwab & Co., Inc. The document reports 98,490,606 shares outstanding for the issuer and indicates no sales in the prior three months. On face value, this is a routine Rule 144 notice documenting an insider's exercise and planned disposition rather than a corporate operational disclosure.

Corporate Governance Expert

TL;DR: Routine insider sale disclosure with standard attestation; nothing in the filing signals governance irregularities.

The filer represents by signing that they are not aware of undisclosed material adverse information. The transaction is described as an employee stock option exercise with broker payment for a cashless exercise. The filing records the broker name and sale mechanics, and shows "Nothing to Report" for prior three-month sales. Based solely on the information provided, this is a compliance-driven disclosure under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	4110	993562.00	98490606	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/11/2025	Employee Stock Option Exercise	STERIS plc			4110	08/11/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did STERIS (STE) report on Form 144?

The filing reports a proposed sale of 4,110 ordinary shares valued at $993,562.00, with an approximate sale date of 08/11/2025.

How were the shares acquired according to the Form 144?

The securities were acquired on 08/11/2025 via an employee stock option exercise and paid through a broker cashless exercise.

Who is the broker handling the proposed sale for STE?

The broker listed is Charles Schwab & Co., Inc., 3000 Schwab Way, Westlake TX 76262.

How many STERIS shares are listed as outstanding in the filing?

The filing shows 98,490,606 shares outstanding for the issuer.

Does the filing report any securities sold in the past three months for STE?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.